This introduces an additional concern
[18] [19] [20] In March 2024, resmetirom was the first drug approved by the FDA for MASH
That part never changes
The Care Coaching Component Unlike simple prescription-and-ship models, WellMedr's materials describe an included Medical Weight-Care Coaching component with provider oversight, coaching modules, and follow-up support
They come across as passive-aggressive and go overboard by referencing treatment timelines, provider interactions, and follow-up appointments in a public setting
Tirzepatide in New York Medical, Insurance and Pricing Disclaimer This article is for general educational purposes only and does not provide medical advice, insurance advice, a diagnosis, a prescription or a guarantee of treatment eligibility